PA-BENTLEY-SYSTEMS
26.4.2018 08:02:10 CEST | Business Wire | Press release
Bentley Systems, Incorporated, a leading global provider of comprehensive software solutions for advancing infrastructure , today announced the acquisition of Plaxis , the leading provider of geotechnical software, based in Delft, Netherlands, and the agreement to acquire soil engineering software provider SoilVision , based in Saskatchewan, Canada. The acquisitions, with Bentley’s market-leading borehole reporting and data management software gINT, serve to make Bentley a complete source for geotechnical professionals “going digital.” Finally, BIM advancements can be extended to the essential subsurface engineering of every infrastructure project.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180425006935/en/
Projects necessarily begin with geotechnical surveys and sampling, captured with gINT for versatile documentation and reporting. Next, professionals perform engineering related to soil properties, soil behavior, and groundwater flow using SoilVision’s SVOFFICE applications, supplemented by Plaxis’ offerings. Then soil-structure interaction is analyzed through Plaxis ’ design, simulation, and engineering software (e.g. PLAXIS 2D, PLAXIS 3D).
The new opportunity, by way of digital workflows enabled through Bentley’s comprehensive modeling environment, is for geotechnical applications to be integrated with Bentley’s structural applications (such as STAAD, RAM, and SACS) for unprecedented geo-structural engineering performance. As changes may occur in owner requirements, structural strategies, or site conditions (continuously surveyed through UAVs and Bentley’s ContextCapture for reality modeling), geotechnical analysis could be continuously applied for improved outcomes, as managed through ProjectWise collaboration services.
For today’s infrastructure demands, geotechnical considerations are coming to the fore. Urbanization, for instance, drives growth both vertically and underground, with emphasis on the capacity of foundations and tunnels. And new infrastructure projects of every type depend upon constructed dams, embankments, dikes, levees, and reservoirs to improve their resilience. Moreover, new asset types such as offshore wind turbine structures require new geotechnical analysis capabilities, in this case to be accomplished with Plaxis’ forthcoming MoDeTo software.
Because infrastructure assets are crucially linked to subsurface environs, they are vulnerable to geo-environmental risks including seismic activity, subsidence, and weather impacts. Leveraging new digital workflows which incorporate real-time monitoring and analytics during infrastructure operations, geotechnical professionals can play the increasingly valuable role they deserve in achieving geo-environmental resilience.
Bentley Systems CEO, Greg Bentley said, “My colleagues and I welcome our new teams from Plaxis and SoilVision, which have in common a zeal for applying science for better engineering practice. Dr. Ronald Brinkgreve from Plaxis and Dr. Murray Fredlund, founder of SoilVision , exemplify this. I believe that every geotechnical engineer has benefitted from Plaxis’ continuous advancement, in scope and quality, of tools for their discipline to add value. With a professional and dedicated management team led by Jan-Willem Koutstaal, Plaxis has become one of the most successful software businesses I have ever seen.”
Bentley added, “While most infrastructure engineering disciplines converged around intuitive 3D models, geotechnical applications seem to have followed a less graphically intensive development path, and so have remained isolated from cross-discipline workflows. This ‘disconnected’ mindset prevailed even while Plaxis , SoilVision , and gINT mainstreamed 3D innovations. Our BIM platform’s comprehensive modeling environment will finally embrace the geotechnical profession in digital workflows for every infrastructure project and asset.”
Tony O’Brien, global practice leader for geotechnics for Mott MacDonald, said, “PLAXIS is one of our core analysis tools being used across our global geotechnics practice. When used by experienced specialists, PLAXIS can analyze many of our most complex ground-structure interaction problems. In Bentley’s hands, we have high expectations that we can accomplish more through digital workflows made possible through integration of PLAXIS technology with Bentley’s comprehensive modeling environment—workflows that are compatible with Mott MacDonald’s commitment to connected thinking and solving complex infrastructure challenges.”
About Plaxis
Plaxis is a global market leader in geotechnical engineering software based on the finite element method, offering its applications to users in more than 100 countries worldwide. With a well-established reputation as the industry standard for geotechnical design, Plaxis software serves project owners, contractors, and consultants in civil engineering, oil and gas, offshore industries, and governmental organizations. www.plaxis.com
About SoilVision
Founded in 1997, SoilVision has championed 3D conceptual design and analysis of slope stability, groundwater flow, stress/deformation, contaminant transport, thermal flows in saturated/unsaturated soils, and coupled processes for geotechnical engineers and hydrogeologists. The software solves complex problems by performing numerical modeling and analysis of earth structures in the areas of soil and rock slope stability of earth dams, open pits, levees, embankments, and retaining walls. The software has been utilized for basic designs as well as advanced unsaturated analysis. The software is utilized extensively in the mining industry for the design and evaluation of large engineered earth structures. www.soilvision.com
About Bentley Systems
Bentley Systems is a global leader in providing engineers, architects, geospatial professionals, constructors, and owner-operators with comprehensive software solutions for advancing the design, construction, and operations of infrastructure. Bentley users leverage information mobility across disciplines and throughout the infrastructure lifecycle to deliver better-performing projects and assets. Bentley solutions encompass MicroStation applications for information modeling , ProjectWise collaboration services to deliver integrated projects , and AssetWise operations services to achieve intelligent infrastructure – complemented by comprehensive managed services offered through customized Success Plans.
Founded in 1984, Bentley has more than 3,500 colleagues in over 50 countries, more than $700 million in annual revenues, and since 2012 has invested more than $1 billion in research, development, and acquisitions. www.bentley.com
Related Images:
PLAXIS
3D
Caption:
PLAXIS 3D performs three-dimensional
analysis of deformation, soil-structure interaction, and stability in
geotechnical engineering and rock mechanics.
SoilVision
Caption:
SoilVision applications provide capabilities for engineering related to
soil properties, soil behavior, and groundwater flow.
##
Bentley, the “B” Bentley logo, AssetWise, ContextCapture, gINT, MicroStation, ProjectWise, RAM, SACS, and STAAD are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries. All other brands and product names are trademarks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180425006935/en/
Contact:
Bentley Systems
Press:
Jennifer Maguire, +1 610 458 2695
jennifer.maguire@bentley.com
Follow
us on Twitter:
@BentleySystems
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
